Radio and PodcastRadio and PodcastLive Radio & Podcasts
Ep. 379 - Argenx M&A, AI giants and biopharma, catalyst scorecard artwork
Science & Medicine

Ep. 379 - Argenx M&A, AI giants and biopharma, catalyst scorecard

BioCentury This Week by BioCentury

Jul 27, 202634:09Science & Medicine

Argenx the tier-jumping European biotech, believes its proposed $2.2 billion purchase of Forte Biosciences will add a second multi-indication product upon which it can run the strategy that has made autoimmune drug Vyvga...

About This Episode

Ep. 379 - Argenx M&A, AI giants and biopharma, catalyst scorecard is an episode from BioCentury This Week by BioCentury. Argenx the tier-jumping European biotech, believes its proposed $2.2 billion purchase of Forte Biosciences will add a s...

Podcast

This episode belongs to BioCentury This Week.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jul 27, 2026, 34:09 long, audio available.

Related Episodes

Continue listening to more episodes from BioCentury This Week.